At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AAIC Arlington Asset Investment Corp
Closed 04-03 16:00:00 EDT
4.84
+0.00
0.00%
| High4.84 | Low4.84 | Vol0.00 |
| Open4.84 | D1 Closing4.84 | Amplitude0.00% |
| Mkt Cap137.08M | Tradable Cap130.81M | Total Shares28.32M |
| T/O0.00 | T/O Rate0.00% | Tradable Shares27.03M |
| P/B0.76 | ROE0.20% | EPS-0.08 |
| 52wk High4.84 | 52wk Low2.53 | P/E-61.27 |
| Dividend0.23 | Div.Yield0.05 | ROA0.04% |
Longeveron® Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel (Lomecel-BTM) in Alzheimer’s Disease
GlobeNewswire · 03-20
Press Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update
Dow Jones · 03-13
NKGen Biotech, Inc. to Transition from the Nasdaq Global Market to OTC Markets; Reverse Stock Split will not be Implemented
GlobeNewswire · 03-04
Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates
GlobeNewswire · 02-27
FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US
PR Newswire · 01-27
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
Benzinga · 01-14
Vigil Neuroscience Highlights 2024 Corporate Achievements and Upcoming 2025 Milestones
GlobeNewswire · 01-08
ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights
GlobeNewswire · 2024-11-14
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results
GlobeNewswire · 2024-11-12
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results
Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire · 2024-11-12
Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire · 2024-11-07
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire · 2024-11-05
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality
Business Wire · 2024-10-31
Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality
Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
GlobeNewswire · 2024-09-26
Introduction
Company Name.
Arlington Asset Investment Corp
Affiliated Markets:
NYSE
Listing Date:
1997-12-23
Main Business:
Arlington Asset Investment Corp. (NYSE: AAIC) currently invests primarily in mortgage related and residential real estate and has elected to be taxed as a REIT. The Company is headquartered in the Washington, D.C. metropolitan area. For more information, please visit www.arlingtonasset.com.
Issue price:
--
Invest in Global Markets with Tiger Brokers!Open App